CIK-Cell Study 01 (#583)
Laufzeit: 01.01.2016 - 31.12.2040
Kurzfassung
A prospective phase I/II study to investigate the feasibility, safety and efficacy of IL-15 activated cytokine induced killer (CIK) cells in relapsing patients with acute leukemia or myelodysplastic syndromes after allogeneic stem cell transplantation
